0.0550CAD-8.33%Mkt Cap: 18.04M CADP/E: —Last update: 2026-06-01
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers S…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap18.04M CAD
Enterprise Value27.16M CAD
Revenue (TTM)473.27K CAD
Gross Profit147.57K CAD
Net Income (TTM)-6.29M CAD
Revenue/Share0.0020 CAD
Last Price0.0550 CAD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryCA
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)Infinity
PEG—
EV/EBITDA-6.41
EV/Revenue57.40
P/S41.57
P/B-1.82
EPS (TTM)-0.02
EPS (Forward)0.00
52W Range
0.040025% of range0.1000
52W High0.1000 CAD
52W Low0.0400 CAD
Profitability
Gross Margin31.18%
Oper. Margin-914.29%
EBITDA Margin0.00%
Profit Margin-1329.15%
ROE64.59%
ROA-895.65%
Growth
Revenue Growth-26.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.73M CAD
CapEx (TTM)2.10K CAD
FCF Margin-710.35%
FCF Yield-18.64%
Net Debt7.96M CAD
Net Debt/EBITDA-1.88
Balance Sheet
Debt/Equity-0.82
Current Ratio0.04
Quick Ratio0.01
Book Value/Sh-0.0330 CAD
Cash/Share0.0000 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.2800 CAD
Target Range0.2800 CAD – 0.2800 CAD
# Analysts1
Ownership
Shares Out.327.93M
Float209.40M
Insiders27.44%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short6.46K
Short (prev mo.)52.47K
Technical
SMA 500.0572 (-3.8%)
SMA 2000.0618 (-11.0%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)85.16K
Avg Vol (10d)82.65K
Technical Indicators
RSI (14)56.2
MACD0.0002
MACD Signal-0.0008
MACD Hist.+0.0009
BB Upper0.0647 CAD
BB Middle0.0550 CAD
BB Lower0.0453 CAD
BB Width35.39%
ATR (14)0.0040 CAD
Vol Ratio (20d)0.12x